ARCA biopharma, Inc. stock is up 8.89% since 30 days ago. The next earnings date is Feb 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 59.26% of the previous 26 November’s closed higher than October.
ARCA biopharma, Inc. develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 and Gencaro.